200 related articles for article (PubMed ID: 27858992)
1. SOX12: a novel potential target for acute myeloid leukaemia.
Wan H; Cai J; Chen F; Zhu J; Zhong J; Zhong H
Br J Haematol; 2017 Feb; 176(3):421-430. PubMed ID: 27858992
[TBL] [Abstract][Full Text] [Related]
2. LncRNA SNHG1 contributes to the regulation of acute myeloid leukemia cell growth by modulating miR-489-3p/SOX12/Wnt/β-catenin signaling.
Li C; Gao Q; Wang M; Xin H
J Cell Physiol; 2021 Jan; 236(1):653-663. PubMed ID: 32592199
[TBL] [Abstract][Full Text] [Related]
3. miR-342-3p Inhibits Acute Myeloid Leukemia Progression by Targeting SOX12.
Wang Y; Guo X; Wang L; Xing L; Zhang X; Ren J
Oxid Med Cell Longev; 2022; 2022():1275141. PubMed ID: 36120594
[TBL] [Abstract][Full Text] [Related]
4. SOX12 promotes the growth of multiple myeloma cells by enhancing Wnt/β-catenin signaling.
Gao Y; Li L; Hou L; Niu B; Ru X; Zhang D
Exp Cell Res; 2020 Mar; 388(1):111814. PubMed ID: 31904384
[TBL] [Abstract][Full Text] [Related]
5. Proliferation and bone marrow engraftment of AML blasts is dependent on β-catenin signalling.
Siapati EK; Papadaki M; Kozaou Z; Rouka E; Michali E; Savvidou I; Gogos D; Kyriakou D; Anagnostopoulos NI; Vassilopoulos G
Br J Haematol; 2011 Jan; 152(2):164-74. PubMed ID: 21118196
[TBL] [Abstract][Full Text] [Related]
6. DIXDC1 promotes the growth of acute myeloid leukemia cells by upregulating the Wnt/β-catenin signaling pathway.
Xin H; Li C; Wang M
Biomed Pharmacother; 2018 Nov; 107():1548-1555. PubMed ID: 30257373
[TBL] [Abstract][Full Text] [Related]
7. A novel genome-wide in vivo screen for metastatic suppressors in human colon cancer identifies the positive WNT-TCF pathway modulators TMED3 and SOX12.
Duquet A; Melotti A; Mishra S; Malerba M; Seth C; Conod A; Ruiz i Altaba A
EMBO Mol Med; 2014 Jul; 6(7):882-901. PubMed ID: 24920608
[TBL] [Abstract][Full Text] [Related]
8. A novel dipeptide type inhibitor of the Wnt/β-catenin pathway suppresses proliferation of acute myelogenous leukemia cells.
Wakabayashi R; Hattori Y; Hosogi S; Toda Y; Takata K; Ashihara E
Biochem Biophys Res Commun; 2021 Jan; 535():73-79. PubMed ID: 33341676
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal COX2-PG secretome engages NR4A-WNT signalling axis in haematopoietic progenitors to suppress anti-leukaemia immunity.
Wu L; Amarachintha S; Xu J; Oley F; Du W
Br J Haematol; 2018 Nov; 183(3):445-456. PubMed ID: 30106181
[TBL] [Abstract][Full Text] [Related]
10. Suppression of SOX7 by DNA methylation and its tumor suppressor function in acute myeloid leukemia.
Man CH; Fung TK; Wan H; Cher CY; Fan A; Ng N; Ho C; Wan TS; Tanaka T; So CW; Kwong YL; Leung AY
Blood; 2015 Jun; 125(25):3928-36. PubMed ID: 25940713
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneous sensitivity of human acute myeloid leukemia to β-catenin down-modulation.
Gandillet A; Park S; Lassailly F; Griessinger E; Vargaftig J; Filby A; Lister TA; Bonnet D
Leukemia; 2011 May; 25(5):770-780. PubMed ID: 21339756
[TBL] [Abstract][Full Text] [Related]
12. HOTAIRM1 knockdown enhances cytarabine-induced cytotoxicity by suppression of glycolysis through the Wnt/β-catenin/PFKP pathway in acute myeloid leukemia cells.
Chen L; Hu N; Wang C; Zhao H
Arch Biochem Biophys; 2020 Feb; 680():108244. PubMed ID: 31904363
[TBL] [Abstract][Full Text] [Related]
13. Sox17 and Sox4 differentially regulate beta-catenin/T-cell factor activity and proliferation of colon carcinoma cells.
Sinner D; Kordich JJ; Spence JR; Opoka R; Rankin S; Lin SC; Jonatan D; Zorn AM; Wells JM
Mol Cell Biol; 2007 Nov; 27(22):7802-15. PubMed ID: 17875931
[TBL] [Abstract][Full Text] [Related]
14. SOX1 functions as a tumor suppressor by antagonizing the WNT/β-catenin signaling pathway in hepatocellular carcinoma.
Tsao CM; Yan MD; Shih YL; Yu PN; Kuo CC; Lin WC; Li HJ; Lin YW
Hepatology; 2012 Dec; 56(6):2277-87. PubMed ID: 22767186
[TBL] [Abstract][Full Text] [Related]
15. TRIM31 promotes acute myeloid leukemia progression and sensitivity to daunorubicin through the Wnt/β-catenin signaling.
Xiao Y; Deng T; Ming X; Xu J
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32232394
[TBL] [Abstract][Full Text] [Related]
16. γ-Catenin is overexpressed in acute myeloid leukemia and promotes the stabilization and nuclear localization of β-catenin.
Morgan RG; Pearn L; Liddiard K; Pumford SL; Burnett AK; Tonks A; Darley RL
Leukemia; 2013 Feb; 27(2):336-43. PubMed ID: 22858986
[TBL] [Abstract][Full Text] [Related]
17. Constitutive activation of the Wnt/beta-catenin signalling pathway in acute myeloid leukaemia.
Simon M; Grandage VL; Linch DC; Khwaja A
Oncogene; 2005 Mar; 24(14):2410-20. PubMed ID: 15735743
[TBL] [Abstract][Full Text] [Related]
18. CD82 regulates STAT5/IL-10 and supports survival of acute myelogenous leukemia cells.
Nishioka C; Ikezoe T; Yang J; Nobumoto A; Kataoka S; Tsuda M; Udaka K; Yokoyama A
Int J Cancer; 2014 Jan; 134(1):55-64. PubMed ID: 23797738
[TBL] [Abstract][Full Text] [Related]
19. Increased FLYWCH1 Expression is Negatively Correlated with Wnt/β-catenin Target Gene Expression in Acute Myeloid Leukemia Cells.
Almars A; Chondrou PS; Onyido EK; Almozyan S; Seedhouse C; Babaei-Jadidi R; Nateri AS
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31167387
[TBL] [Abstract][Full Text] [Related]
20. HCK maintains the self-renewal of leukaemia stem cells via CDK6 in AML.
Li Z; Wang F; Tian X; Long J; Ling B; Zhang W; Xu J; Liang A
J Exp Clin Cancer Res; 2021 Jun; 40(1):210. PubMed ID: 34167558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]